Concepedia

Michael Cukan

MC

8

Publications

905

Citations

8

H-Index

2006

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Michael Cukan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in glycobiology, biotechnology, and protein engineering.

ORCID

Top concepts

Publications per year

2006–2012

8

Publications

8

Optimization of humanized IgGs in glycoengineered Pichia pastoris

Huijuan Li, Natarajan Sethuraman, Terrance A. Stadheim et al. · Nature Biotechnology · 2006 · 422 citations

, , +5

Production of monoclonal antibodies by glycoengineered Pichia pastoris

Thomas I. Potgieter, Michael Cukan, J. E. Drummond et al. · Journal of Biotechnology · 2008 · 157 citations

, , +4

IgG2m4, an engineered antibody isotype with reduced Fc function

Zhiqiang An, Gail Forrest, Renée Moore et al. · mAbs · 2009 · 97 citations · Full text

Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study

Ningyan Zhang, Calin Dan Dumitru, Nga Rewa Houston Cummings et al. · mAbs · 2011 · 92 citations · Full text

Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response

Byung‐Kwon Choi, Jeffrey K. Actor, Sandra Rios et al. · Glycoconjugate Journal · 2008 · 71 citations · Full text

, , +9

Rows per page

1–5 of 8